LACTOSE (INDIA)
Back to Income Statement
|
LACTOSE (INDIA) Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹116 Cr | ₹114 Cr | ₹66 Cr | ₹46 Cr | ₹35 Cr |
What is the latest Revenue of LACTOSE (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹116 Cr |
| Mar2024 | ₹114 Cr |
| Mar2023 | ₹66 Cr |
| Mar2022 | ₹46 Cr |
| Mar2021 | ₹35 Cr |
How is Revenue of LACTOSE (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹116 Cr | 2.20 | |
| Mar2024 | ₹114 Cr | 73.10 | |
| Mar2023 | ₹66 Cr | 43.22 | |
| Mar2022 | ₹46 Cr | 31.39 | |
| Mar2021 | ₹35 Cr | - | |
Compare Revenue of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹127.2 Cr | -4.8% | -4.4% | -22.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -4.8% |
-4.4% |
-22.8% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses